Finance
Results: 2449-2460 of 43927

BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

New Partnership between SC Johnson, U.S. Department of State and the Global Fund Could Help Protect 60 Million People from Malaria







